In conclusion, our results suggested a potential role for Nanog overexpression in modulating the neurotoxic effects of Aβ, which implies that strategies to enhance insulin signaling by overexpression of Nanog could be used as an intervention for AD treatment. Here, INS is linked to Alzheimer disease.